Search Results - "CLOUD, G. A"

Invasive Fungal Infections in Low‐Risk Liver Transplant Recipients: A Multi‐Center Prospective Observational Study by Pappas, P. G., Andes, D., Schuster, M., Hadley, S., Rabkin, J., Merion, R. M., Kauffman, C. A., Huckabee, C., Cloud, G. A., Dismukes, W. E., Karchmer, A. W.

“…Prevention of invasive fungal infections (IFIs) in orthotopic liver transplant (OLT) recipients utilizing postoperative systemic antifungal prophylaxis,…”
Get full text

Distribution of Health Care Expenditures for HIV-Infected Patients by Chen, Ray Y., Accortt, Neil A., Westfall, Andrew O., Mugavero, Michael J., Raper, James L., Cloud, Gretchen A., Stone, Beth K., Carter, Jerome, Call, Stephanie, Pisu, Maria, Allison, Jeroan, Saag, Michael S.

“…Background. Health care expenditures for persons infected with human immunodeficiency virus (HIV) in the United State determined on the basis of actual health…”
Get full text

Comparison of immune recovery in recipients of unmanipulated vs T-cell-depleted grafts from unrelated donors in a multicenter randomized phase II-III trial (T-cell depletion trial) by Keever-Taylor, C A, Wagner, J E, Kernan, N A, Small, T N, Carter, S L, Thompson, J S, Cloud, G A, Lamb, L S

Get full text

Duration of Highly Active Antiretroviral Therapy Regimens by Chen, Ray Y., Westfall, Andrew O., Mugavero, Michael J., Cloud, Gretchen A., Raper, James L., Chatham, Ashlee G., Acosta, Edward P., Taylor, Kelly H., Carter, Jerome, Saag, Michael S.

“…The median duration of highly active antiretroviral therapy (HAART) regimens was reported to be 11.8 months in one US study, but that study included both…”
Get full text

A Randomized Study of the Use of Fluconazole in Continuous versus Episodic Therapy in Patients with Advanced HIV Infection and a History of Oropharyngeal Candidiasis: AIDS Clinical Trials Group Study 323/Mycoses Study Group Study 40 by Goldman, Mitchell, Cloud, Gretchen A., Wade, Karen D., Reboli, Annette C., Fichtenbaum, Carl J., Hafner, Richard, Sobel, Jack D., Powderly, William G., Patterson, Thomas F., Wheat, Lawrence J., Stein, David K., Dismukes, William E., Filler, Scott G.

“…Background. In human immunodeficiency virus (HIV)–infected patients, fluconazole prophylaxis is associated with reductions in the rate of fungal infection…”
Get full text

Measurement of Cryptococcal Antigen in Serum and Cerebrospinal Fluid: Value in the Management of AIDS-Associated Cryptococcal Meningitis by Powderly, William G., Cloud, Gretchen A., Dismukes, William E., Saag, Michael S.

“…The value of monitoring titers of cryptococcal antigen in serum and cerebrospinal fluid (CSF) during therapy for AIDS-associated cryptococcal meningitis was…”
Get full text

Itraconazole Prophylaxis for Fungal Infections in Patients with Advanced Human Immunodeficiency Virus Infection: Randomized, Placebo-Controlled, Double-Blind Study by McKinsey, David S., Wheat, L. Joseph, Cloud, Gretchen A., Pierce, Mark, Black, John R., Bamberger, David M., Goldman, Mitchell, Thomas, Carolynn J., Gutsch, Heidi M., Moskovitz, Bruce, Dismukes, William E., Kauffman, Carol A.

“…In a prospective, randomized, double-blind trial, 149 patients with advanced human immunodeficiency virus (HIV) infection were randomized to receive…”
Get full text

Working Parents: The Impact of Day Care and Breast-Feeding on Cytomegalovirus Infections in Offspring by Stagno, Sergio, Cloud, Gretchen A.

“…The increase in the popularity of breast feeding and utilization of child care arrangements are having a major effect on the epidemiology of cytomegalovirus…”
Get full text

Is it ever safe to stop azole therapy for Coccidioides immitis meningitis ? by DEWSNUP, D. H, GALGIANI, J. N, GRAYBILL, J. R, DIAZ, M, RENDON, A, CLOUD, G. A, STEVENS, D. A

“…To determine 1) whether patients with coccidioidal meningitis who had achieved remission with oral azole therapy were cured and 2) when oral azole therapy…”
Get full text

Comparison of Amphotericin B with Fluconazole in the Treatment of Acute AIDS-Associated Cryptococcal Meningitis by Saag, Michael S, Powderly, William G, Cloud, Gretchen A, Robinson, Patrick, Grieco, Michael H, Sharkey, Patricia K, Thompson, Sumner E, Sugar, Alan M, Tuazon, Carmelita U, Fisher, John F, Hyslop, Newton, Jacobson, Jeffrey M, Hafner, Richard, Dismukes, William E

“…CRYPTOCOCCAL meningitis, the most common life-threatening opportunistic fungal disease in patients infected with the human immunodeficiency virus (HIV) type 1,…”
Get full text

Fluconazole Therapy for Histoplasmosis by McKinsey, David S., Kauffman, Carol A., Pappas, Peter G., Cloud, Gretchen A., Girard, William M., Sharkey, Patricia K., Hamill, Richard J., Thomas, Carolynn J., Dismukes, William E.

“…We assessed the efficacy of oral fluconazole (200–800 mg daily) in the treatment of non-lifethreatening acute pulmonary histoplasmosis, chronic pulmonary…”
Get full text

Treatment of Blastomycosis with Fluconazole: A Pilot Study by Pappas, Peter G., Bradsher, Robert W., Chapman, Stanley W., Kauffman, Carol A., Dine, Alan, Cloud, Gretchen A., Dismukes, William E.

“…There are few clinical data concerning the use of fluconazole, a triazole antifungal agent with in vitro activity against Blastomyces dermatitidis, in the…”
Get full text

Safety, Tolerance, and Efficacy of Posaconazole Therapy in Patients with Nonmeningeal Disseminated or Chronic Pulmonary Coccidioidomycosis by Catanzaro, Antonino, Cloud, Gretchen A., Stevens, David A., Levine, Bernard E., Williams, Paul L., Johnson, Royce H., Rendon, Adrian, Mirels, Laurence F., Lutz, Jon E., Holloway, Melissa, Galgiani, John N.

“…Background. Coccidioidomycosis can be difficult to treat with available therapies, particularly in patients with progressive or disseminated disease…”
Get full text

Fluconazole therapy for coccidioidal meningitis by GALGIANI, J. N, CATANZARO, A, CLOUD, G. A, HUGGS, J, FRIEDMAN, B. A, LARSEN, R. A, GRAYBILL, J. R

“…The objective of this study was to determine the efficacy and safety of fluconazole treatment of coccidioidal meningitis in an uncontrolled clinical trial at…”
Get full text

Treatment of Lymphocutaneous and Visceral Sporotrichosis with Fluconazole by Kauffman, Carol A., Pappas, Peter G., McKinsey, David S., Greenfield, Ronald A., Perfect, John R., Cloud, Gretchen A., Thomas, Carolynn J., Dismukes, William E.

“…Thirty patients with documented sporotrichosis were treated with 200–800 mg of fluconazole daily. Fourteen patients had lymphocutaneous infection; only five…”
Get full text

Treatment of Blastomycosis with Higher Doses of Fluconazole by Pappas, Peter G., Bradsher, Robert W., Kauffman, Carol A., Cloud, Gretchen A., Thomas, Carolynn J., Campbell, G. Douglas, Chapman, Stanley W., Newman, Cheryl, Dismukes, William E.

“…Recent clinical data suggest that fluconazole at daily doses of 200 to 400 mg for at least 6 months is moderately effective therapy for non-life-threatening…”
Get full text

Sexual contact tracing outcome in adolescent chlamydial and gonococcal cervicitis cases by Oh, M. Kim, Boker, John R., Genuardi, Frank J., Cloud, Gretchen A., Reynolds, Julia, Hodgens, J. Bart

“…Treatment of sex partners is an essential part of sexually transmitted diseases (STD) control. This study examined the efficacy of contact tracing via patient…”
Get full text

Cryptococcosis in Human Immunodeficiency Virus-Negative Patients in the Era of Effective Azole Therapy by Pappas, Peter G., Perfect, John R., Cloud, Gretchen A., Larsen, Robert A., Pankey, George A., Lancaster, Daniel J., Henderson, Harold, Kauffman, Carol A., Haas, David W., Saccente, Michael, Hamill, Richard J., Holloway, Melissa S., Warren, Robert M., Dismukes, William E.

“…We conducted a case study of human immunodeficiency virus (HIV)-negative patients with cryptococcosis at 15 United States medical centers from 1990 through…”
Get full text

Cerebrospinal Fluid Antibodies Detected by ELISA against a 33-kDa Antigen from Spherules of Coccidioides immitis in Patients with Coccidioidal Meningitis by Galgiani, John N., Peng, Tao, Lewis, Maria L., Cloud, Gretchen A., Pappagianis, Demosthenes

“…Antibodies against a 33-kDa antigen from Coccidioides immitis were detected by ELISA in patients' cerebrospinal fluid (CSF). Anti-33-kDa antibodies were…”
Get full text

Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry by Kilby, J. Michael, Saag, Michael S, Hopkins, Sam, Venetta, Thomas M, DiMassimo, Betty, Cloud, Gretchen A, Lee, Jeannette Y, Alldredge, Leslie, Hunter, Eric, Lambert, Dennis, Bolognesi, Dani, Matthews, Thomas, Johnson, M. Ross, Nowak, Martin A, Shaw, George M

“…T-20, a synthetic peptide corresponding to a region of the transmembrane subunit of the HIV-1 envelope protein, blocks cell fusion and viral entry at…”
Get full text